TY - JOUR AU - Baranda, Joaquina C. AU - Godwin, Andrew K. PY - 2019 TI - Advancing the promises of precision medicine for patients with gastrointestinal stromal tumor JF - Gastrointestinal Stromal Tumor; Vol 2 (December 2019): Gastrointestinal Stromal Tumor Y2 - 2019 KW - N2 - Gastrointestinal stromal tumor (GIST) treatment is one of the best examples of how precision medicine can impact outcomes in patients with cancer. In 1998, Hirota and colleagues reported that GISTs carried gain-of-function mutations in the proto-oncogene, c-KIT (1). Although considered a rare malignancy, GIST is the most common mesenchymal neoplasm of the gastrointestinal tract (2-4). UR - https://gist.amegroups.org/article/view/33704